Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Scutellaria baicalensis extract on inflammatory biomarkers and performance in transition dairy cows.

Journal of dairy science·2026
Same author

Comparison between a complete preconditioning programme and conventional conduct on behaviour, health and performance of young bulls from small cow-calf herds.

Animal : an international journal of animal bioscience·2024
Same author

[Hepatopulmonary syndrome].

La Revue de medecine interne·2023
Same author

[Dysfunction of endothelial BMP-9 signaling in pulmonary vascular disease].

Revue des maladies respiratoires·2023
Same author

[Hepatopulmonary syndrome: Prevalence, pathophysiology and clinical implications].

Revue des maladies respiratoires·2022
Same author

Correction: Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein.

Oncogene·2021

Related Experiment Video

Updated: May 23, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

eIF4F suppression in breast cancer affects maintenance and progression.

Z Nasr1, F Robert, J A Porco

  • 1Department of Biochemistry, McGill University, Montreal, Quebec, Canada.

Oncogene
|April 10, 2012
PubMed
Summary

Elevated eukaryotic initiation factor 4E (eIF4E) drives breast cancer progression. Suppressing the mammalian target of rapamycin (mTOR)/eIF4F pathway inhibits tumor growth, metastasis, and invasion, suggesting therapeutic potential.

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Related Experiment Videos

Last Updated: May 23, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Elevated eukaryotic initiation factor 4E (eIF4E) is common in human cancers.
  • High eIF4E levels are linked to poor prognosis in some cancers.

Purpose of the Study:

  • To investigate the role of mammalian target of rapamycin (mTOR) signaling in breast cancer progression.
  • To determine the impact of targeting the mTOR/eIF4F pathway on breast cancer growth and metastasis.

Main Methods:

  • Utilized transgenic and allograft breast cancer models.
  • Assessed the effects of suppressing mTOR activity and eIF4E/eIF4A levels and activity.
  • Evaluated breast cancer cell invasion and migration in vitro.
  • Measured the translation of specific mRNAs (VEGF, MMP9, cyclin D1).

Main Results:

  • Increased mTOR signaling significantly contributes to breast cancer progression in vivo.
  • Suppression of mTOR, eIF4E, and eIF4A delayed tumor progression and pulmonary metastasis.
  • Inhibition of eIF4E reduced breast cancer cell invasion and migration.
  • eIF4E suppression inhibited the translation of VEGF, MMP9, and cyclin D1 mRNAs.

Conclusions:

  • The mTOR/eIF4F axis is crucial for breast cancer maintenance and progression.
  • Targeting the mTOR/eIF4F pathway shows therapeutic potential for breast cancer treatment.